72 related articles for article (PubMed ID: 20110201)
1. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
Duarte AF; Correia O; Azevedo R; do Carmo Palmares M; Delgado L
Eur J Dermatol; 2010; 20(2):236-8. PubMed ID: 20110201
[No Abstract] [Full Text] [Related]
2. Etoricoxib-induced acute generalized exanthematous pustulosis.
Mäkelä L; Lammintausta K
Acta Derm Venereol; 2008; 88(2):200-1. PubMed ID: 18311467
[No Abstract] [Full Text] [Related]
3. Fixed drug eruption by etoricoxib confirmed by patch test.
Sousa AS; Cardoso JC; Gouveia MP; Gameiro AR; Teixeira VB; Gonçalo M
An Bras Dermatol; 2016; 91(5):652-654. PubMed ID: 27828643
[TBL] [Abstract][Full Text] [Related]
4. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.
Andrade P; Gonçalo M
Contact Dermatitis; 2011 Feb; 64(2):118-20. PubMed ID: 21210830
[No Abstract] [Full Text] [Related]
5. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
6. Fixed drug eruption and generalised erythema following etoricoxib.
Augustine M; Sharma P; Stephen J; Jayaseelan E
Indian J Dermatol Venereol Leprol; 2006; 72(4):307-9. PubMed ID: 16880582
[No Abstract] [Full Text] [Related]
7. Etoricoxib-induced erythema-multiforme-like eruption.
Thirion L; Nikkels AF; Piérard GE
Dermatology; 2008; 216(3):227-8. PubMed ID: 18182814
[TBL] [Abstract][Full Text] [Related]
8. Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
Wong EH; Leung TW; Wong KS
J Neuroimaging; 2007 Jan; 17(1):87-8. PubMed ID: 17238877
[TBL] [Abstract][Full Text] [Related]
9. A case report on toxic epidermal necrolysis with etoricoxib.
Kameshwari JS; Devde R
Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
[TBL] [Abstract][Full Text] [Related]
10. Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
Ponce V; Muñoz-Bellido F; Moreno E; Laffond E; González A; Dávila I
Contact Dermatitis; 2012 Feb; 66(2):107-8. PubMed ID: 22233472
[No Abstract] [Full Text] [Related]
11. [Brief coxib therapy lowers cardiovascular risk].
Z Orthop Ihre Grenzgeb; 2006; 144(1):18. PubMed ID: 16498555
[No Abstract] [Full Text] [Related]
12. Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Schwartz JI; Agrawal NG; Wong PH; Miller J; Bachmann K; Marbury T; Hoelscher D; Cavanaugh PF; Gottesdiener K
J Clin Pharmacol; 2009 Oct; 49(10):1202-9. PubMed ID: 19783714
[TBL] [Abstract][Full Text] [Related]
13. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs.
Di Leo E; Aloia AM; Nettis E; Cardinale F; Foti C; Distaso M; Ferrannini A; Vacca A
Int J Immunopathol Pharmacol; 2009; 22(4):1131-4. PubMed ID: 20074479
[TBL] [Abstract][Full Text] [Related]
14. Etoricoxib-induced fixed drug eruption with positive lesional patch tests.
Calistru AM; Cunha AP; Nogueira A; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):154-6. PubMed ID: 21108578
[TBL] [Abstract][Full Text] [Related]
15. Etoricoxib-induced toxic epidermal necrolysis.
Moutran R; Maatouk I; Hélou J
Int J Dermatol; 2014 Apr; 53(4):e275-7. PubMed ID: 23879726
[No Abstract] [Full Text] [Related]
16. Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats.
Baracho NC; Guizelli GP; Carmello BL; Sanches Dde S; Silva FM; Reis JM; Brito Jd
Acta Cir Bras; 2009; 24(3):206-10. PubMed ID: 19504003
[TBL] [Abstract][Full Text] [Related]
17. Etoricoxib: a French review of adverse effects.
Prescrire Int; 2014 Feb; 23(146):45. PubMed ID: 24669387
[TBL] [Abstract][Full Text] [Related]
18. Approval of etoricoxib is unacceptable! Authorised and reimbursed in France, despite an unfavourable risk-benefit balance.
Prescrire Int; 2010 Aug; 19(108):158. PubMed ID: 20939443
[No Abstract] [Full Text] [Related]
19. Fixed drug eruption due to etoricoxib in a patient with tolerance to celecoxib: the value of patch testing.
Gómez de la Fuente E; Pampín Franco A; Caro Gutiérrez D; López Estebaranz JL
Actas Dermosifiliogr; 2014 Apr; 105(3):314-5. PubMed ID: 24661957
[No Abstract] [Full Text] [Related]
20. Few options available for arthritis pain relief. FDA declines to approve Merck's Arcoxia.
Young D
Am J Health Syst Pharm; 2007 May; 64(10):1020-2. PubMed ID: 17494894
[No Abstract] [Full Text] [Related]
[Next] [New Search]
